Overview
Patient-reported Outcomes in the Treatment of Schizophrenia
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
Patient-reported health economic outcomes for patients enrolled in S1543003 and S1543004 protocolsPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Solvay Pharmaceuticals
Criteria
Inclusion Criteria:- Participate in S1543003 and S1543004 in the U.S. sites
Exclusion Criteria:
- Participate in S1543003 and S1543004 other than U.S. sites